SEP 14 2008 KOSOBBL ,p. | of, |
510K) Summary
Submitter: Cynosure, Inc.
10 Elizabeth Driv:
Chelmsford, MA 01824
Contact: George Cho .
Senior Vice Presic ent of Medical Technology
Date Summary Prepared: February 14, 2005
Device Trade Name: Affinity QS Q-Sw tched Nd:YAG Laser system
(Common Name: Q-Switched Nd:Y AG laser
Classification Name: Instrument, surgiciil, powered, laser
79-GEX
21 CFR 878.48
Equivalent Device: Medlite C6 Q-Swi ched Nd:YAG Laser system
Device Description: The Affinity QS Q-Switched Nd:YAG Laser is a Q-Switched,
frequency doubled laser system. It provides both 1064nm and 532nm
wavelengths.
Laser emission act vation is by foot switch. Overall weight of the laser
is 180 Ibs., and the size is 25" x 15" x 78" (LxWxH).
Electrical requirenent is 230 VAC, 20A, 50-60 Hz, single phase.
hitended Use: The Affinity QS laser is intended for treatment of vascular lesions,
pigmented lesions, and for hair, tattoo removal, and the incision,
excision, ablation, vaporization of soft tissue for general dermatology.
Comparison: The Affinity QS la:er system has identical indication for use, the same
principle of operation, and essentially the same wavelength range and
pulse energy range as the predicate device.
Nonclinical Performance Data: none
Clinical Performance Data: none
Conclusion: The Affinity QS laser is a safe and effective device for the treatment of
vascular and pigme ited lesions, for hair and tattoo removal, and for
the incision, excisic n, ablation, vaporization of soft tissue for general
dermatology.
Additional Information: none

: 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
vot Food and Drug Administration
9200 Corporate Boulevard
SEP 14 2005 Rockville MD 20850
Mr. George Cho
Senior Vice President
Medical Technoogy
Cynosure Incorporated
10 Elizabeth Drive
Chelmsford, Massachusetts 01 824
Re: K050382
Trade/Device Name: Cynosure Affinity QS Laser
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general
and plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: August 31, 2005
Received: September 2, 2005
Dear Mr.Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, Jabeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CER Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2- Mr. George Cho

This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.

. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain. htm]

foot yours,

Mark N. Melkerson

Acting Director

Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

«
510(k) Number (if known): K OSD38X
Device Name: _Cynosure Affinity OS Laser
Indications For Use:
The Affinity QS Laser is intended for the treat nent of vascular lesions, pigmented lesions, and for
hair removal, tattoo removal, and the incision, excision, ablation, vaporization of soft tissue for
general dermatology.
Prescriptive Use___X_ OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
_ _ _ _
Concurrence of CDRH, C*ffice of Device Evaluation (ODE)
Ces Py ed A WAN
(Vivision Sign-Off) ‘
Division of General, Re a
and Neurological Devices
J 2
510(k) Number 09 02% a
Prescription Use & oR Over-The-Counter Use______.
(Optional Format 1-2-96)

